Personalizing cardiac regenerative therapy: At the heart of Pim1 kinase

Kaitlen Samse, Nirmala Hariharan, Mark A. Sussman

Research output: Contribution to journalReview article

4 Citations (Scopus)

Abstract

During cardiac aging, DNA damage and environmental stressors contribute to telomeric shortening and human cardiac progenitor cells acquire a senescent phenotype that leads to decreased stem cell function. Reversion of this phenotype through genetic modification is essential to advance regenerative therapy. Studies in the cardiac specific overexpression and subcellular targeting of Pim1 kinase demonstrate its influence on regeneration, proliferation, survival, metabolism and senescence. The cardioprotective effects of Pim1 modification can be picked apart and enhanced by targeting the kinase to distinct subcellular compartments, allowing for selection of specific phenotypic traits after molecular modification. In this perspective, we examine the therapeutic implications of Pim1 to encourage the personalization of cardiac regenerative therapy.

Original languageEnglish (US)
Pages (from-to)13-16
Number of pages4
JournalPharmacological Research
Volume103
DOIs
StatePublished - Jan 1 2016
Externally publishedYes

Fingerprint

Phosphotransferases
Stem Cells
Phenotype
DNA Damage
Regeneration
Therapeutics
Survival

Keywords

  • Aging
  • Apoptosis
  • Heart failure
  • Human cardiac progenitor cell
  • Pim1
  • Senescence

ASJC Scopus subject areas

  • Pharmacology

Cite this

Personalizing cardiac regenerative therapy : At the heart of Pim1 kinase. / Samse, Kaitlen; Hariharan, Nirmala; Sussman, Mark A.

In: Pharmacological Research, Vol. 103, 01.01.2016, p. 13-16.

Research output: Contribution to journalReview article

@article{00caecdda9c5469ab61008a782189929,
title = "Personalizing cardiac regenerative therapy: At the heart of Pim1 kinase",
abstract = "During cardiac aging, DNA damage and environmental stressors contribute to telomeric shortening and human cardiac progenitor cells acquire a senescent phenotype that leads to decreased stem cell function. Reversion of this phenotype through genetic modification is essential to advance regenerative therapy. Studies in the cardiac specific overexpression and subcellular targeting of Pim1 kinase demonstrate its influence on regeneration, proliferation, survival, metabolism and senescence. The cardioprotective effects of Pim1 modification can be picked apart and enhanced by targeting the kinase to distinct subcellular compartments, allowing for selection of specific phenotypic traits after molecular modification. In this perspective, we examine the therapeutic implications of Pim1 to encourage the personalization of cardiac regenerative therapy.",
keywords = "Aging, Apoptosis, Heart failure, Human cardiac progenitor cell, Pim1, Senescence",
author = "Kaitlen Samse and Nirmala Hariharan and Sussman, {Mark A.}",
year = "2016",
month = "1",
day = "1",
doi = "10.1016/j.phrs.2015.11.001",
language = "English (US)",
volume = "103",
pages = "13--16",
journal = "Pharmacological Research",
issn = "1043-6618",
publisher = "Academic Press Inc.",

}

TY - JOUR

T1 - Personalizing cardiac regenerative therapy

T2 - At the heart of Pim1 kinase

AU - Samse, Kaitlen

AU - Hariharan, Nirmala

AU - Sussman, Mark A.

PY - 2016/1/1

Y1 - 2016/1/1

N2 - During cardiac aging, DNA damage and environmental stressors contribute to telomeric shortening and human cardiac progenitor cells acquire a senescent phenotype that leads to decreased stem cell function. Reversion of this phenotype through genetic modification is essential to advance regenerative therapy. Studies in the cardiac specific overexpression and subcellular targeting of Pim1 kinase demonstrate its influence on regeneration, proliferation, survival, metabolism and senescence. The cardioprotective effects of Pim1 modification can be picked apart and enhanced by targeting the kinase to distinct subcellular compartments, allowing for selection of specific phenotypic traits after molecular modification. In this perspective, we examine the therapeutic implications of Pim1 to encourage the personalization of cardiac regenerative therapy.

AB - During cardiac aging, DNA damage and environmental stressors contribute to telomeric shortening and human cardiac progenitor cells acquire a senescent phenotype that leads to decreased stem cell function. Reversion of this phenotype through genetic modification is essential to advance regenerative therapy. Studies in the cardiac specific overexpression and subcellular targeting of Pim1 kinase demonstrate its influence on regeneration, proliferation, survival, metabolism and senescence. The cardioprotective effects of Pim1 modification can be picked apart and enhanced by targeting the kinase to distinct subcellular compartments, allowing for selection of specific phenotypic traits after molecular modification. In this perspective, we examine the therapeutic implications of Pim1 to encourage the personalization of cardiac regenerative therapy.

KW - Aging

KW - Apoptosis

KW - Heart failure

KW - Human cardiac progenitor cell

KW - Pim1

KW - Senescence

UR - http://www.scopus.com/inward/record.url?scp=84947802402&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84947802402&partnerID=8YFLogxK

U2 - 10.1016/j.phrs.2015.11.001

DO - 10.1016/j.phrs.2015.11.001

M3 - Review article

C2 - 26563999

AN - SCOPUS:84947802402

VL - 103

SP - 13

EP - 16

JO - Pharmacological Research

JF - Pharmacological Research

SN - 1043-6618

ER -